688566 吉贝尔
已收盘 07-08 15:00:00
资讯
新帖
简况
股市必读：吉贝尔（688566）7月6日董秘有最新回复
证券之星 · 07-07 02:34
股市必读：吉贝尔（688566）7月6日董秘有最新回复
吉贝尔：抗抑郁新药JJH201501生产批件申报工作正在有序推进中
证券之星 · 07-06 18:21
吉贝尔：抗抑郁新药JJH201501生产批件申报工作正在有序推进中
股市必读：吉贝尔（688566）7月1日董秘有最新回复
证券之星 · 07-02
股市必读：吉贝尔（688566）7月1日董秘有最新回复
股市必读：XD吉贝尔（688566）6月26日董秘有最新回复
证券之星 · 06-29
股市必读：XD吉贝尔（688566）6月26日董秘有最新回复
吉贝尔：公司将结合自身经营情况、发展规划、资本结构等因素综合研判
证券之星 · 06-26
吉贝尔：公司将结合自身经营情况、发展规划、资本结构等因素综合研判
吉贝尔：公司一季度净利润有所承压
证券之星 · 06-24
吉贝尔：公司一季度净利润有所承压
股市必读：吉贝尔（688566）6月22日董秘有最新回复
证券之星 · 06-23
股市必读：吉贝尔（688566）6月22日董秘有最新回复
吉贝尔（688566）披露2025年年度权益分派实施公告，6月17日股价下跌0.9%
证券之星 · 06-17
吉贝尔（688566）披露2025年年度权益分派实施公告，6月17日股价下跌0.9%
吉贝尔(688566)6月10日股东户数0.75万户，较上期增加1.87%
证券之星 · 06-15
吉贝尔(688566)6月10日股东户数0.75万户，较上期增加1.87%
吉贝尔：截至2026年6月10日收市，公司股东总数为7,463户
证券之星 · 06-15
吉贝尔：截至2026年6月10日收市，公司股东总数为7,463户
吉贝尔：公司正在开展新厂区的建设工作
证券之星 · 06-09
吉贝尔：公司正在开展新厂区的建设工作
每周股票复盘：吉贝尔（688566）JJH201501申报进展及利可君片市场拓展
证券之星 · 06-07
每周股票复盘：吉贝尔（688566）JJH201501申报进展及利可君片市场拓展
吉贝尔：公司已于2026年6月1日在东方财富路演平台召开了2025年度暨2026年第一季度业绩说明会
证券之星 · 06-05
吉贝尔：公司已于2026年6月1日在东方财富路演平台召开了2025年度暨2026年第一季度业绩说明会
股市必读：吉贝尔（688566）6月1日披露最新机构调研信息
证券之星 · 06-02
股市必读：吉贝尔（688566）6月1日披露最新机构调研信息
每周股票复盘：吉贝尔（688566）股东户数减少3.88%，户均持股上升
证券之星 · 05-31
每周股票复盘：吉贝尔（688566）股东户数减少3.88%，户均持股上升
吉贝尔(688566)5月20日股东户数0.75万户，较上期减少3.88%
证券之星 · 05-25
吉贝尔(688566)5月20日股东户数0.75万户，较上期减少3.88%
每周股票复盘：吉贝尔（688566）289名激励对象获167万股归属
证券之星 · 05-24
每周股票复盘：吉贝尔（688566）289名激励对象获167万股归属
吉贝尔（688566）披露召开2025年度暨2026年第一季度业绩说明会公告，5月22日股价上涨1.96%
证券之星 · 05-22
吉贝尔（688566）披露召开2025年度暨2026年第一季度业绩说明会公告，5月22日股价上涨1.96%
吉贝尔（688566）披露2025年限制性股票激励计划首次授予部分第一个归属期归属条件成就公告，5月20日股价上涨0.49%
证券之星 · 05-20
吉贝尔（688566）披露2025年限制性股票激励计划首次授予部分第一个归属期归属条件成就公告，5月20日股价上涨0.49%
股市必读：吉贝尔(688566)股东户数0.78万户，较上期减少1.11%
证券之星 · 05-18
股市必读：吉贝尔(688566)股东户数0.78万户，较上期减少1.11%
加载更多
公司概况
公司名称：
江苏吉贝尔药业股份有限公司
所属行业：
医药制造业
上市日期：
2020-05-18
主营业务：
江苏吉贝尔药业股份有限公司的主营业务是药物研发、生产、销售。公司的主要产品是利可君片、尼群洛尔片、玉屏风胶囊、醋氯芬酸肠溶片。公司是国家级专精特新“小巨人”企业。
发行价格：
23.69
{"stockData":{"symbol":"688566","market":"SH","secType":"STK","nameCN":"吉贝尔","latestPrice":25.51,"timestamp":1783494000000,"preClose":26.13,"halted":0,"volume":2240724,"delay":0,"changeRate":-0.0237,"floatShares":200999999,"shares":200999999,"eps":1.2634,"marketStatus":"已收盘","change":-0.62,"latestTime":"07-08 15:00:00","open":26.13,"high":26.49,"low":25.44,"amount":58109100,"amplitude":0.0402,"askPrice":25.51,"askSize":6,"bidPrice":25.46,"bidSize":4,"shortable":0,"etf":0,"ttmEps":1.2634,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1783560600000},"marketStatusCode":5,"adr":0,"adjPreClose":26.13,"symbolType":"stock_kcb","openAndCloseTimeList":[[1783474200000,1783481400000],[1783486800000,1783494000000]],"highLimit":28.74,"lowLimit":23.52,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":201101625,"isCdr":false,"pbRate":2.07,"roa":"--","peRate":20.191547,"roe":"1.71%","epsLYR":1.31,"committee":-0.138889,"marketValue":5130000000,"turnoverRate":0.0111,"status":1,"afterMarket":{"amount":0,"volume":0,"close":25.51,"buyVolume":0,"sellVolume":0,"time":1783496037746,"indexStatus":"已收盘 07-08 15:30:00","preClose":26.13},"floatMarketCap":5130000000},"requestUrl":"/m/hq/s/688566","defaultTab":"news","newsList":[{"id":"2649676300","title":"股市必读：吉贝尔（688566）7月6日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2649676300","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649676300?lang=zh_cn&edition=full","pubTime":"2026-07-07 02:34","pubTimestamp":1783362853,"startTime":"0","endTime":"0","summary":"截至2026年7月6日收盘，吉贝尔报收于26.43元，下跌0.56%，换手率1.53%，成交量3.07万手，成交额8209.1万元。目前，抗抑郁新药JJH201501生产批件申报工作正在按照有关申报要求有序推进中，目前处于申报前的会议沟通阶段，公司将积极做好相关工作，有关具体进展情况，敬请关注公司后续披露的相关信息。投资者： 董秘您好，JJH201501已于2025年10月完成III期临床试验，至今数月，想咨询：上市申报资料是否全部收尾，预计何时正式递交CDE？","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070700001199.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649681623","title":"吉贝尔：抗抑郁新药JJH201501生产批件申报工作正在有序推进中","url":"https://stock-news.laohu8.com/highlight/detail?id=2649681623","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649681623?lang=zh_cn&edition=full","pubTime":"2026-07-06 18:21","pubTimestamp":1783333267,"startTime":"0","endTime":"0","summary":"证券之星消息，吉贝尔07月06日在投资者关系平台上答复投资者关心的问题。目前，抗抑郁新药JJH201501生产批件申报工作正在按照有关申报要求有序推进中，目前处于申报前的会议沟通阶段，公司将积极做好相关工作，有关具体进展情况，敬请关注公司后续披露的相关信息。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070600028390.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648526399","title":"股市必读：吉贝尔（688566）7月1日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2648526399","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648526399?lang=zh_cn&edition=full","pubTime":"2026-07-02 04:16","pubTimestamp":1782936974,"startTime":"0","endTime":"0","summary":"截至2026年7月1日收盘，吉贝尔报收于26.52元，上涨3.63%，换手率1.88%，成交量3.78万手，成交额9881.23万元。董秘最新回复投资者： 请问，截至2026年6月30日公司的股东总数是多少？报告期末的股东人数属于定期报告应当披露的信息，为保证信息披露的公平性，公司将在2026年半年度报告中披露上述信息。交易信息汇总资金流向7月1日主力资金净流入354.17万元，占总成交额0.0%；游资资金净流出1513.71万元，占总成交额0.0%；散户资金净流入1159.55万元，占总成交额0.0%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070200001971.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647345205","title":"股市必读：XD吉贝尔（688566）6月26日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2647345205","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647345205?lang=zh_cn&edition=full","pubTime":"2026-06-29 05:00","pubTimestamp":1782680444,"startTime":"0","endTime":"0","summary":"截至2026年6月26日收盘，吉贝尔报收于23.33元，下跌5.85%，换手率0.65%，成交量1.31万手，成交额3128.56万元。董秘最新回复投资者： 为什么不回购？投资者： 请问截止6月20日，股东人数是多少？截至2026年6月18日收市，公司股东总数为7,453户。公司股东情况敬请关注公司披露的定期报告。当日关注点交易信息汇总：6月26日主力资金净流出225.82万元，占总成交额0.0%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062900001570.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646564923","title":"吉贝尔：公司将结合自身经营情况、发展规划、资本结构等因素综合研判","url":"https://stock-news.laohu8.com/highlight/detail?id=2646564923","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646564923?lang=zh_cn&edition=full","pubTime":"2026-06-26 18:18","pubTimestamp":1782469093,"startTime":"0","endTime":"0","summary":"证券之星消息，XD吉贝尔(688566)06月26日在投资者关系平台上答复投资者关心的问题。投资者提问：为什么不回购？XD吉贝尔回复：尊敬的投资者，您好！感谢您对公司的建议和关注。公司将结合自身经营情况、发展规划、资本结构等因素综合研判，如后续有相关计划，公司将及时公告。感谢您的关注！本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。责任编辑：刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062600034834.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688566","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645932148","title":"吉贝尔：公司一季度净利润有所承压","url":"https://stock-news.laohu8.com/highlight/detail?id=2645932148","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645932148?lang=zh_cn&edition=full","pubTime":"2026-06-24 16:24","pubTimestamp":1782289482,"startTime":"0","endTime":"0","summary":"证券之星消息，吉贝尔06月24日在投资者关系平台上答复投资者关心的问题。谢谢吉贝尔回复：尊敬的投资者，您好！今年第一季度，公司总体经营情况良好，营业收入与核心产品销售规模同步实现增长；报告期内，公司持续开展产品推广布局，加大创新药研发投入，相关费用有所增加，叠加股份支付及新增固定资产折旧（新厂区）等因素影响，导致公司一季度净利润有所承压。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062400029462.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645774030","title":"股市必读：吉贝尔（688566）6月22日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2645774030","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645774030?lang=zh_cn&edition=full","pubTime":"2026-06-23 04:06","pubTimestamp":1782158774,"startTime":"0","endTime":"0","summary":"截至2026年6月22日收盘，吉贝尔报收于24.71元，下跌1.32%，换手率0.53%，成交量1.07万手，成交额2612.04万元。董秘最新回复投资者： 贵公司收购英伟达的好久能对外公布？公司目前没有相关计划。当日关注点交易信息汇总：6月22日主力资金净流出23.93万元，游资资金净流入160.35万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062300003912.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688566","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644491747","title":"吉贝尔（688566）披露2025年年度权益分派实施公告，6月17日股价下跌0.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2644491747","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644491747?lang=zh_cn&edition=full","pubTime":"2026-06-17 23:19","pubTimestamp":1781709553,"startTime":"0","endTime":"0","summary":"截至2026年6月17日收盘，吉贝尔报收于24.23元，较前一交易日下跌0.9%，最新总市值为48.73亿元。该股当日开盘24.34元，最高24.45元，最低24.05元，成交额达1909.17万元，换手率为0.39%。近日，江苏吉贝尔药业股份有限公司发布《2025年年度权益分派实施公告》。公告显示，公司于2026年5月22日经股东会审议通过2025年年度利润分配方案，以总股本201,101,625股为基数，向全体股东每股派发现金红利0.26元（含税），共计派发52,286,422.50元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061700042948.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643746392","title":"吉贝尔(688566)6月10日股东户数0.75万户，较上期增加1.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2643746392","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2643746392?lang=zh_cn&edition=full","pubTime":"2026-06-15 17:42","pubTimestamp":1781516533,"startTime":"0","endTime":"0","summary":"证券之星消息，近日吉贝尔披露，截至2026年6月10日公司股东户数为7463.0户，较5月29日增加137.0户，增幅为1.87%。在化学制药行业个股中，吉贝尔股东户数低于行业平均水平，截至6月10日，化学制药行业平均股东户数为3.54万户。从股价来看，2026年5月29日至2026年6月10日，吉贝尔区间跌幅为6.01%，在此期间股东户数增加137.0户，增幅为1.87%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061500022533.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688566","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643275900","title":"吉贝尔：截至2026年6月10日收市，公司股东总数为7,463户","url":"https://stock-news.laohu8.com/highlight/detail?id=2643275900","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2643275900?lang=zh_cn&edition=full","pubTime":"2026-06-15 15:57","pubTimestamp":1781510237,"startTime":"0","endTime":"0","summary":"证券之星消息，吉贝尔(688566)06月15日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截止6月10日，股东人数是多少？谢谢吉贝尔回复：尊敬的投资者，您好！截至2026年6月10日收市，公司股东总数为7,463户。公司股东情况敬请关注公司披露的定期报告。感谢您的关注！本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061500016609.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688566","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642663554","title":"吉贝尔：公司正在开展新厂区的建设工作","url":"https://stock-news.laohu8.com/highlight/detail?id=2642663554","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642663554?lang=zh_cn&edition=full","pubTime":"2026-06-09 17:27","pubTimestamp":1780997239,"startTime":"0","endTime":"0","summary":"证券之星消息，吉贝尔06月09日在投资者关系平台上答复投资者关心的问题。谢谢吉贝尔回复：尊敬的投资者，您好！感谢您对公司的建议。目前，公司正在开展新厂区的建设工作，包括生产基地（新址）、研发中心、高端制剂研发中心等多个项目，有关具体情况，可查阅公司披露的相关信息。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060900028270.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688566","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641512720","title":"每周股票复盘：吉贝尔（688566）JJH201501申报进展及利可君片市场拓展","url":"https://stock-news.laohu8.com/highlight/detail?id=2641512720","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641512720?lang=zh_cn&edition=full","pubTime":"2026-06-07 03:00","pubTimestamp":1780772439,"startTime":"0","endTime":"0","summary":"截至2026年6月5日收盘，吉贝尔报收于24.04元，较上周的25.13元下跌4.34%。本周，吉贝尔6月1日盘中最高价报25.59元。本周关注点来自机构调研要点：抗抑郁新药JJH201501注册申报正稳步推进，具体进展以信息披露为准。来自机构调研要点：JJH201601已完成IIa期临床受试者入组，处于随访观察阶段。来自机构调研要点：利可君片将加速全国空白市场开发和肿瘤领域推广。问：抗肿瘤新药JJH201601研发的进展如何？","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060700000983.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641115239","title":"吉贝尔：公司已于2026年6月1日在东方财富路演平台召开了2025年度暨2026年第一季度业绩说明会","url":"https://stock-news.laohu8.com/highlight/detail?id=2641115239","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641115239?lang=zh_cn&edition=full","pubTime":"2026-06-05 16:30","pubTimestamp":1780648244,"startTime":"0","endTime":"0","summary":"证券之星消息，吉贝尔06月05日在投资者关系平台上答复投资者关心的问题。然而，贵公司2024年未提供相关回放。公司已于2026年6月1日在东方财富路演平台召开了2025年度暨2026年第一季度业绩说明会，投资者可以通过东方财富路演平台查看本次投资者说明会的召开情况及主要内容。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060500028085.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","LU1064131003.USD","LU1997245177.USD","BK0077","LU1064130708.USD","LU1831875114.USD","LU1981816686.USD","688566","BK0055","LU2495084118.USD","BK0239","300059","LU2097828714.EUR","BK0276","LU2097828474.EUR","BK0028","LU1997245094.SGD","LU2097828805.USD","LU2580892789.USD","BK0188","LU2097828557.USD","LU2148510915.USD","LU2097828631.EUR","LU2289578879.USD","BK0201","LU1997244956.HKD","SG9999014674.SGD","LU2580892862.HKD","LU0326950275.SGD","BK0095"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640697309","title":"股市必读：吉贝尔（688566）6月1日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2640697309","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640697309?lang=zh_cn&edition=full","pubTime":"2026-06-02 02:52","pubTimestamp":1780339934,"startTime":"0","endTime":"0","summary":"截至2026年6月1日收盘，吉贝尔报收于25.32元，上涨0.76%，换手率0.31%，成交量6211.0手，成交额1572.62万元。来自机构调研要点：抗抑郁新药JJH201501注册申报筹备稳步推进，具体进展以公司披露信息为准。来自机构调研要点：抗肿瘤新药JJH201601已完成IIa期临床受试者入组，正处于随访观察阶段。来自机构调研要点：一季度净利润下滑主要受股份支付及新增固定资产折旧因素影响。截至2026年5月29日收市，公司股东总数为7,326户。公司股东情况敬请关注公司披露的定期报告。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060200002202.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688566","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639604489","title":"每周股票复盘：吉贝尔（688566）股东户数减少3.88%，户均持股上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2639604489","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2639604489?lang=zh_cn&edition=full","pubTime":"2026-05-31 03:46","pubTimestamp":1780170373,"startTime":"0","endTime":"0","summary":"截至2026年5月29日收盘，吉贝尔报收于25.13元，较上周的26.5元下跌5.17%。本周，吉贝尔5月25日盘中最高价报26.81元。吉贝尔当前最新总市值50.12亿元，在化学制药板块市值排名93/150，在两市A股市值排名3370/5207。本周关注点股本股东变化：股东户数减少3.88%，户均持股数量增至2.65万股股本股东变化股东户数变动截至2026年5月20日，公司股东户数为7524.0户，较5月8日减少304.0户，减幅为3.88%。户均持股数量由上期的2.55万股增加至2.65万股，户均持股市值为70.32万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026053100001087.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638531338","title":"吉贝尔(688566)5月20日股东户数0.75万户，较上期减少3.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2638531338","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638531338?lang=zh_cn&edition=full","pubTime":"2026-05-25 17:29","pubTimestamp":1779701392,"startTime":"0","endTime":"0","summary":"证券之星消息，近日吉贝尔披露，截至2026年5月20日公司股东户数为7524.0户，较5月8日减少304.0户，减幅为3.88%。在化学制药行业个股中，吉贝尔股东户数低于行业平均水平，截至5月20日，化学制药行业平均股东户数为3.57万户。从股价来看，2026年5月8日至2026年5月20日，吉贝尔区间跌幅为5.92%，在此期间股东户数减少304.0户，减幅为3.88%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052500024465.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637375049","title":"每周股票复盘：吉贝尔（688566）289名激励对象获167万股归属","url":"https://stock-news.laohu8.com/highlight/detail?id=2637375049","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637375049?lang=zh_cn&edition=full","pubTime":"2026-05-24 04:24","pubTimestamp":1779567852,"startTime":"0","endTime":"0","summary":"截至2026年5月22日收盘，吉贝尔报收于26.5元，较上周的26.84元下跌1.27%。本周，吉贝尔5月21日盘中最高价报26.85元。吉贝尔当前最新总市值52.85亿元，在化学制药板块市值排名94/150，在两市A股市值排名3374/5206。股票来源为公司向激励对象定向发行A股普通股。公司同时审议通过《关于作废部分2025年限制性股票激励计划首次授予部分已授予尚未归属的限制性股票的议案》，因个人绩效考核未达标及部分激励对象离职，合计作废419,280股已授予但尚未归属的限制性股票。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052400001356.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688566","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637934835","title":"吉贝尔（688566）披露召开2025年度暨2026年第一季度业绩说明会公告，5月22日股价上涨1.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2637934835","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637934835?lang=zh_cn&edition=full","pubTime":"2026-05-22 22:37","pubTimestamp":1779460634,"startTime":"0","endTime":"0","summary":"截至2026年5月22日收盘，吉贝尔报收于26.5元，较前一交易日上涨1.96%，最新总市值为52.85亿元。该股当日开盘26.18元，最高26.62元，最低26.02元，成交额达2085.21万元，换手率为0.4%。近日，江苏吉贝尔药业股份有限公司发布《关于召开2025年度暨2026年第一季度业绩说明会的公告》。投资者可于2026年5月29日16:00前通过邮件或电话提交问题。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052200045404.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688566","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636193825","title":"吉贝尔（688566）披露2025年限制性股票激励计划首次授予部分第一个归属期归属条件成就公告，5月20日股价上涨0.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2636193825","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636193825?lang=zh_cn&edition=full","pubTime":"2026-05-20 22:42","pubTimestamp":1779288136,"startTime":"0","endTime":"0","summary":"近日，江苏吉贝尔药业股份有限公司披露《第四届董事会第二十二次会议决议公告》，其中审议通过《关于2025年限制性股票激励计划首次授予部分第一个归属期归属条件成就的议案》。同时，董事会审议通过《关于作废部分2025年限制性股票激励计划首次授予部分已授予尚未归属的限制性股票的议案》，因个人绩效考核未达标及部分激励对象离职，合计作废419,280股已授予但尚未归属的限制性股票。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052000043570.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636501669","title":"股市必读：吉贝尔(688566)股东户数0.78万户，较上期减少1.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2636501669","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636501669?lang=zh_cn&edition=full","pubTime":"2026-05-18 03:50","pubTimestamp":1779047423,"startTime":"0","endTime":"0","summary":"截至2026年5月15日收盘，吉贝尔报收于26.84元，下跌1.32%，换手率0.93%，成交量1.85万手，成交额4957.17万元。来自公司公告汇总：吉贝尔召开2025年年度股东会，审议包括利润分配预案、续聘2026年度审计机构等多项议案。股本股东变化股东户数变动近日吉贝尔披露，截至2026年5月8日公司股东户数为7828.0户，较4月30日减少88.0户，减幅为1.11%。户均持股数量由上期的2.52万股增加至2.55万股，户均持股市值为71.84万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051800001587.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688566"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1783536286773,"stockEarnings":[{"period":"1week","weight":-0.0381},{"period":"1month","weight":0.0888},{"period":"3month","weight":-0.188},{"period":"6month","weight":-0.1662},{"period":"1year","weight":-0.0979},{"period":"ytd","weight":-0.1366}],"compareEarnings":[{"period":"1week","weight":-0.0344},{"period":"1month","weight":0.0029},{"period":"3month","weight":0.0012},{"period":"6month","weight":-0.0363},{"period":"1year","weight":0.1354},{"period":"ytd","weight":0.0005}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"江苏吉贝尔药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"7453人(较上一季度减少0.13%)","perCapita":"26982股","listingDate":"2020-05-18","address":"江苏省镇江市润州区高新技术产业开发园区","registeredCapital":"20110万元","survey":" 江苏吉贝尔药业股份有限公司的主营业务是药物研发、生产、销售。公司的主要产品是利可君片、尼群洛尔片、玉屏风胶囊、醋氯芬酸肠溶片。公司是国家级专精特新“小巨人”企业。","listedPrice":23.69},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"吉贝尔(688566)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供吉贝尔(688566)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"吉贝尔,688566,吉贝尔股票,吉贝尔股票老虎,吉贝尔股票老虎国际,吉贝尔行情,吉贝尔股票行情,吉贝尔股价,吉贝尔股市,吉贝尔股票价格,吉贝尔股票交易,吉贝尔股票购买,吉贝尔股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"吉贝尔(688566)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供吉贝尔(688566)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}